AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 249.57B |
| Enterprise Value | 276.02B |
| Trailing P/E | 39.09 |
| Forward P/E | 17.21 |
| PEG Ratio (5 yr expected) | 0.90 |
| Price/Sales (ttm) | 5.12 |
| Price/Book (mrq) | 6.32 |
| Enterprise Value/Revenue | 5.62 |
| Enterprise Value/EBITDA | 19.60 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.17 |
| 52-Week Change 3 | 18.81% |
| S&P500 52-Week Change 3 | 23.29% |
| 52 Week High 3 | 87.68 |
| 52 Week Low 3 | 60.47 |
| 50-Day Moving Average 3 | 81.43 |
| 200-Day Moving Average 3 | 72.78 |
Share Statistics
| Avg Vol (3 month) 3 | 4.34M |
| Avg Vol (10 day) 3 | 5.41M |
| Shares Outstanding 5 | 3.1B |
| Implied Shares Outstanding 6 | 3.12B |
| Float 8 | 1.54B |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 17.09% |
| Shares Short (Aug 15, 2024) 4 | 5.71M |
| Short Ratio (Aug 15, 2024) 4 | 1.64 |
| Short % of Float (Aug 15, 2024) 4 | N/A |
| Short % of Shares Outstanding (Aug 15, 2024) 4 | 0.27% |
| Shares Short (prior month Jul 15, 2024) 4 | 5.8M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 1.49 |
| Forward Annual Dividend Yield 4 | 1.84% |
| Trailing Annual Dividend Rate 3 | 2.97 |
| Trailing Annual Dividend Yield 3 | 3.66% |
| 5 Year Average Dividend Yield 4 | 2.39 |
| Payout Ratio 4 | 70.39% |
| Dividend Date 3 | Sept 09, 2024 |
| Ex-Dividend Date 4 | Aug 09, 2024 |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Jul 27, 2015 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 13.11% |
| Operating Margin (ttm) | 22.42% |
Management Effectiveness
| Return on Assets (ttm) | 7.68% |
| Return on Equity (ttm) | 16.74% |
Income Statement
| Revenue (ttm) | 49.13B |
| Revenue Per Share (ttm) | 2.63 |
| Quarterly Revenue Growth (yoy) | 13.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | 16.97B |
| Net Income Avi to Common (ttm) | 6.44B |
| Diluted EPS (ttm) | 2.06 |
| Quarterly Earnings Growth (yoy) | 6.00% |
Balance Sheet
| Total Cash (mrq) | 7.08B |
| Total Cash Per Share (mrq) | 4.57 |
| Total Debt (mrq) | 33.65B |
| Total Debt/Equity (mrq) | 84.97% |
| Current Ratio (mrq) | 0.89 |
| Book Value Per Share (mrq) | 25.49 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 11.06B |
| Levered Free Cash Flow (ttm) | 9.82B |
© 2024 Yahoo. All rights reserved.